PowerPoint Presentation

TROG 05.01 trial (POST trial)

post op XRT vs. post op chemo-XRT in high risk cSCC H&N (local T3-T4 TNM 6 th ed. and/or nodal disease)

XRT 60-66Gy/30-33#

phase III

ASCO 2017: addition of weekly CarboPt did not improve outcomes